Covid-19 Vaccine Will Be Circulated Before Chrismas

 Vaccines produced by Pfizer Inc and BioNTech are likely to get the truth from the United States (US) and the European Union (EU) at least the next month after the final exam decision shows as much as 95% success and no serious side impressions.

The order of the vaccine has proven consistent for all ranks of age and people, once it is a good sign and Covid-19 gives a serious impression on the golden and black people.

According to BioNTech Chief Executive Ugur Sahin, the US Food and Drug Administration (FDA) may pass the vaccine out in the middle of next month when it is likely to get conditional pass over the EU in the second half of December.

"If all goes well, I imagine we might get graduation in the second half of December and start delivery before Christmas Day but only if everything goes well," said Sahin.

Sahin added, his party would ask for the truth of the Use of Anxiety (EUA) from the US tomorrow.

Meanwhile, according to a source, an FDA advisory force is planning to meet on December 8-10 to discuss the vaccine. The FDA however did not provide any comments regarding the case.

Meanwhile, Pfizer announced that as many as 50 million dosages of vaccine will be produced this year, sufficient to protect 25 million people and will produce 1.3 billion dosages next year.

Overnight, Pfizer said it was offering millions of vaccine doses to Brazil in the first half of next year. The company has also reached agreements with the EU, Germany and Japan for vaccine distribution to begin next year.

The degree of vaccine viability developed by the two companies with respect to it is much higher than that determined by the health authorities. Health experts say the achievement is significant in the effort to end the pandemic.